Get the Stockscreener App
16.23
2.35%
-0.39
After Hours:
16.23
Kraneshares Msci All China Health Care Index Etf stock is traded at $16.23, with a volume of 4,170.
It is down -2.35% in the last 24 hours and down -7.31% over the past month.
See More
Previous Close:
$16.62
Open:
$16.23
24h Volume:
4,170
Relative Volume:
0.10
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-3.62%
1M Performance:
-7.31%
6M Performance:
-20.28%
1Y Performance:
+7.70%
1-Day Range:
$16.16
$16.35
1-Week Range:
$16.12
$16.77
52-Week Range:
$13.23
$21.88
Kraneshares Msci All China Health Care Index Etf Stock (KURE) Company Profile
Name
Kraneshares Msci All China Health Care Index Etf
Sector
Industry
Phone
-
Address
-
Compare KURE vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KURE
Kraneshares Msci All China Health Care Index Etf
|
16.23 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
319.55 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
State Street Spdr S P 500 Etf Trust
|
645.09 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
648.01 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
261.74 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
573.79 | 124.43B | 0 | 0 | 0 | 0.00 |
Kraneshares Msci All China Health Care Index Etf Stock (KURE) Latest News
Trading the Move, Not the Narrative: (KURE) Edition - Stock Traders Daily
China ETF News: Retail Sales Beat Estimates - Seeking Alpha
KURE Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
(KURE) Volatility Zones as Tactical Triggers - Stock Traders Daily
KURE vs. VHT: Comparing China and U.S. Healthcare ETFs - TipRanks
Price-Driven Insight from (KURE) for Rule-Based Strategy - Stock Traders Daily
KURE, EEMA, CHIH: Get Exposure to Chinese Technology Through Healthcare ETFs - TipRanks
(KURE) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
(KURE) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
5 Biggest Pharmaceutical ETFs for Investors in 2026 - Nasdaq
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks' - Benzinga
(KURE) Movement as an Input in Quant Signal Sets - Stock Traders Daily
ETFs Investing in XtalPi Holdings Limited Stocks - TradingView — Track All Markets
Beyond U.S. Tech Stocks — Top Asia AI Opportunities for 2026 - TheStreet Pro
Understanding the Setup: (KURE) and Scalable Risk - Stock Traders Daily
KraneShares TrustKraneShares MSCI All China Health Care Index ETF announces Annual dividend, payable on December 23, 2025 - MarketScreener
7 Best China ETFs for December 2025 - NerdWallet
Syfe 2025 Thematic Portfolios Reoptimisation: Enhancing China Growth, Tech, ESG, and Healthcare Exposure - Syfe
Precision Trading with Kraneshares Msci All China Health Care Index Etf (KURE) Risk Zones - news.stocktradersdaily.com
5 Biggest Pharmaceutical ETFs in 2025 - Nasdaq
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove… - inkl
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' - Benzinga
KURE - KraneShares
KCAI - KraneShares
KEMX - KraneShares
KGRN - KraneShares
KBA - KraneShares
KraneShares MSCI All China Health Care Index ETF Trade Ideas — AMEX:KURE - TradingView
KraneShares MSCI All China Health Care Index ETF (NY: - FinancialContent
KraneShares SSE STAR Market 50 Index ETF (KSTR) stock price, news, quote and history - Yahoo! Finance Australia
Should EM Investors Trim or Retain Their China Exposure? - ETF Database
ETFs Investing in Innovent Biologics, Inc. Stocks - TradingView
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms - Benzinga
Capitalize on China Healthcare Fundraising With KURE - ETF Database
ETFs Investing in WuXi AppTec Co., Ltd. Class A Stocks - TradingView
Investing in Emerging Markets: CNXT, KSTR and More Top-Performing ETFs - NerdWallet
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing - Benzinga
China Update: New IPOs, Healthcare Momentum, New Hydroelectric Dam - Seeking Alpha
China Thematic Update: New IPOs (KSTR), Healthcare Momentum From Regulatory Reprieve & Innovation (KURE), New Hydroelectric Dam (KGRN) - KraneShares
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains' - Sahm
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies - Benzinga
KURE: Capitalizing on China’s Healthcare Revolution - KraneShares
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare' - Yahoo Finance
KraneShares MSCI All China Health Care Index ETF (KURE) Short Interest Ratio and Volume 2025 - MarketBeat
Best Roth IRA Investments - NerdWallet
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion - Benzinga
About UsGreat American Insurance GroupSpecialty Property & Casualty Insurance - FinancialContent
China's Healthcare ETFs Outpace U.S. Competitors - ETF Trends
3 ETFs Thriving in April’s Market Chaos—Are You Missing Out? - MarketBeat
3 ETFs Thriving in April's Market Chaos-Are You Missing Out? - MSN
Kraneshares Msci All China Health Care Index Etf Stock (KURE) Financials Data
There is no financial data for Kraneshares Msci All China Health Care Index Etf (KURE). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):